肺超声与静脉淤血超声在急性失代偿性心力衰竭危重患者减容前后与心内压的相关性
前瞻性单中心观察性预试验,纳入20例入住心脏ICU并置入肺动脉导管的急性失代偿性心衰成人患者,共40对减容前后配对评估。减容后右房压下降9.2 mm Hg、肺动脉楔压下降12.8 mm Hg,同时VExUS分级下降1.3、门静脉搏动分数下降19.9%、肾静脉淤血指数下降0.19、简化肺超声评分下降11分。VExUS分级与门静脉搏动分数在减容前后均与右房压相关但不与肺动脉楔压相关;简化肺超声评分在基线与减容后均与肺动脉楔压相关。作者认为这些发现支持VExUS与简化肺超声用于急性失代偿性心衰危重患者的减容血流动力学监测。
要点
- 减容后右房压下降9.2 mm Hg(95%CI -12.4至-5.9,p≤0.0001)、肺动脉楔压下降12.8 mm Hg(95%CI -16.6至-9.1,p≤0.0001)。
- 减容后VExUS分级下降1.3(95%CI -1.8至-0.7,p=0.0002),门静脉搏动分数下降19.9%(95%CI -34.1至-5.6,p=0.0075)。
- VExUS分级与门静脉搏动分数在减容前后均与右房压相关(减容前p=0.02与p≤0.003,减容后p=0.01与p=0.001),但均不与肺动脉楔压相关。
- 简化肺超声评分与肺动脉楔压在基线(ρ=0.82,p<0.001)和减容后(ρ=0.59,p=0.05)相关,减容前与右房压无显著相关。
- VExUS各亚组成分中,门静脉搏动分数的可重复性较高。
适用人群与场景
- 入住心脏ICU并置入肺动脉导管进行血流动力学指导减容的急性失代偿性心衰成人患者。
研究设计与关键结果
- 前瞻性单中心观察性预试验,20例患者共40对减容前后配对评估。
- 减容后右房压下降9.2 mm Hg(95%CI -12.4至-5.9,p≤0.0001),肺动脉楔压下降12.8 mm Hg(95%CI -16.6至-9.1,p≤0.0001)。
- 减容后VExUS分级下降1.3(95%CI -1.8至-0.7,p=0.0002),门静脉搏动分数下降19.9%(95%CI -34.1至-5.6,p=0.0075),肾静脉淤血指数下降0.19(95%CI -0.38至0,p=0.04),简化肺超声评分下降11分(95%CI -14.2至-8.5,p≤0.0001)。
- VExUS分级与门静脉搏动分数在减容前(p=0.02与p≤0.003)和减容后(p=0.01与p=0.001)均与右房压相关,但均不与肺动脉楔压相关。
- 简化肺超声评分与肺动脉楔压在基线(ρ=0.82,p<0.001)和减容后(ρ=0.59,p=0.05)相关,减容前与右房压无显著相关。
- VExUS各亚组成分中,门静脉搏动分数可重复性较高。
证据类型、等级与局限
- 证据类型:前瞻性单中心观察性预试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现支持VExUS与简化肺超声在急性失代偿性心衰危重患者减容血流动力学监测中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Venous congestion contributes to multiple organ dysfunction and mortality in critically ill patients. The venous excess ultrasound (VExUS) and lung ultrasound scores have been shown to reflect cardiac filling pressures, but their ability to track hemodynamic changes during decongestion in critically ill patients remains unclear.
OBJECTIVES: To determine the correlation of lung ultrasound and VExUS scores with intracardiac filling pressures before and after decongestion in critically ill patients with acute decompensated heart failure.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a prospective single-center observational pilot study of adults admitted to the cardiac intensive care and who underwent pulmonary artery catheter placement for hemodynamic-guided decongestion. We performed paired measurements of VExUS grade, simplified lung ultrasound (sLUS) scores, and calculated the renal venous stasis index (RVSI) before and after decongestion and assessed for changes and correlation with right atrial pressure (RAP) and pulmonary artery occlusion pressure (PAOP).
MEASUREMENTS AND MAIN RESULTS: Twenty patients underwent 40-paired assessments. After decongestion, a significant reduction in RAP (-9.2 mm Hg; 95% CI, -12.4 to -5.9 mm Hg; p ≤ 0.0001) and PAOP (-12.8 mm Hg; 95% CI, -16.6 to -9.1 mm Hg; p ≤ 0.0001) mirrored reductions in VExUS grades (-1.3; 95% CI, -1.8 to -0.7; p = 0.0002), portal vein pulsatility fraction (-19.9%; 95% CI, -34.1 to -5.6; p = 0.0075), RVSI (-0.19; 95% CI, -0.38 to 0; p = 0.04), and sLUS (-11 points; 95% CI, -14.2 to -8.5; p ≤ 0.0001). VExUS grades and portal vein pulsatility fraction correlated with RAP both before (p = 0.02 and p ≤ 0.003) and after (p = 0.01 and p = 0.001) decongestion, but neither correlated with PAOP. sLUS correlated with PAOP at baseline (ρ = 0.82; p < 0.001) and following decongestion (ρ = 0.59; p = 0.05), while showing no significant correlation with RAP pre-decongestion.
CONCLUSIONS AND RELEVANCE: In critically ill patients with acute decompensated heart failure, we observed changes in VExUS and sLUS scores with decongestion which mirrored changes in intracardiac pressures. The portal vein pulsatility fraction had the higher reproducibility of the VExUS subcomponents. These findings support the role of VExUS and sLUS in hemodynamic monitoring of decongestion in critically ill patients with acute decompensated heart failure.
参考来源
- Jimenez JV, Narula S, Callegari S, et al. Lung and Venous Excess Ultrasound Correlation With Intracardiac Pressures Before and After Decongestion in Critically Ill Patients With Acute Decompensated Heart Failure. Crit Care Explor. 2026. PMID: 41805782. doi:10.1097/CCE.0000000000001385
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。